KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Ann: Kazia releases preliminary Cantrixil Phase I data, page-15

  1. kickst@rter
    2,988 Posts.
    lightbulb Created with Sketch. 258
    clock Created with Sketch.
    19/06/18
    11:37
    Post #: 33792660
    We are only in part A of the phase. Dose escalation has not been trialled yet and we already have two patients with stable disease and one with a partial response to the drug. Part B explores efficacy due to dose escalation. Toxicity profile sounds positive for dose escalation. Our Part B is really a Phase 2 study on phase 1 part A patients, correct me if I am wrong.
    KZA Price at posting: 60.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Exploration drilling confirms large gold system at Abercromby Gold Project
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Trump just dropped a 200% tariff bomb. Here's how to cash in
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
NEWS Blue Moon first wedge hole intersects 543g/t gold over 1.2m in laminated quartz vein
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.